Emmaus Life Sciences (EMMA) EBIT Margin (2010 - 2026)
Emmaus Life Sciences (EMMA) posted EBIT Margin of 60.00% for Q2 2026, up 73.14 percentage points from -13.13% a year earlier and up 101.53 percentage points from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) EBIT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Emmaus Life Sciences was 29.29%, up 37.05 percentage points year-over-year; for FY2025, it came in at 1.85%, up 13.23 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +1.99 percentage points (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' EBIT Margin was -11.37% in FY2024 (-23.33 pp), 11.96% in FY2023 (+47.77 pp), -35.81% in FY2022 (-6.08 pp) and -29.73% in FY2021 (-29.60 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin in data going back to Q3 2010.
- On a year-over-year basis, EBIT Margin increased in five of the last eight quarters, with an average year-over-year change of +17.61 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2022, with a gain of 140.49 percentage points; the weakest was Q4 2021, with a drop of 170.18 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -41.52% (Q1 2026), 23.00% (Q4 2025) and 20.57% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 28.37% |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 60.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.00% |
| Mar 31, 2026 | -41.52% |
| Dec 31, 2025 | 23.00% |
| Sep 30, 2025 | 20.57% |
| Jun 30, 2025 | -13.13% |
| Mar 31, 2025 | -40.73% |
| Dec 31, 2024 | -16.92% |
| Sep 30, 2024 | 14.99% |
| Jun 30, 2024 | 10.82% |
| Mar 31, 2024 | -109.34% |
| Dec 31, 2023 | 19.17% |
| Sep 30, 2023 | 0.48% |
| Jun 30, 2023 | 30.91% |
| Mar 31, 2023 | -17.25% |
| Dec 31, 2022 | -23.91% |
| Sep 30, 2022 | -13.36% |
| Jun 30, 2022 | -33.59% |
| Mar 31, 2022 | -94.87% |
| Dec 31, 2021 | -164.40% |
| Sep 30, 2021 | -0.54% |
API Access
Emmaus Life Sciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();